Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study
Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 166

Showing 1-25 of 166 citing articles:

Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Anika Singanayagam, Seran Hakki, Jake Dunning, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. 183-195
Open Access | Times Cited: 753
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2127-2135
Open Access | Times Cited: 533
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1128-e1136
Open Access | Times Cited: 389
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
Yang Liu, Jianying Liu, Bryan A. Johnson, et al.
Cell Reports (2022) Vol. 39, Iss. 7, pp. 110829-110829
Open Access | Times Cited: 345
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1621-1626
Open Access | Times Cited: 285
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2108-2110
Open Access | Times Cited: 234
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy
Azizul Haque, Anudeep B. Pant
Journal of Autoimmunity (2022) Vol. 127, pp. 102792-102792
Open Access | Times Cited: 164
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
Yang Liu, Jianying Liu, Bryan A. Johnson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 159
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
Piotr Rzymski, Barbara Poniedziałek, Andrzej Fal
Vaccines (2021) Vol. 9, Iss. 11, pp. 1286-1286
Open Access | Times Cited: 148
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 141
Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 134
Shedding of Infectious SARS-CoV-2 Despite Vaccination
Kasen K. Riemersma, Luis A. Haddock, Nancy A. Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 117
Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated individuals
Stephen M. Kissler, Joseph R. Fauver, Christina Mack, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 114
Should children be vaccinated against COVID-19?
Petra Zimmermann, Laure F. Pittet, Adam Finn, et al.
Archives of Disease in Childhood (2021) Vol. 107, Iss. 3, pp. e1.4-e8
Open Access | Times Cited: 113
Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
Paul A. Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2021) Vol. 192, Iss. 2, pp. 320-331
Open Access | Times Cited: 110
Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2
Stephen M. Kissler, Joseph R. Fauver, Christina Mack, et al.
medRxiv (2021)
Open Access | Times Cited: 103
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
Bao V. Duong, Puchanee Larpruenrudee, Tianxin Fang, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4586-4586
Open Access | Times Cited: 91
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
Stephanie N. Langel, Susan Johnson, C Martínez, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 658
Open Access | Times Cited: 91
SARS-CoV-2 variant Delta rapidly displaced variant Alpha in the United States and led to higher viral loads
Alexandre Bolze, Shishi Luo, Simon White, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 3, pp. 100564-100564
Open Access | Times Cited: 80
The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission
David W. Eyre, Donald Taylor, M. B. Purver, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 97
COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
Piotr Rzymski, Carlos A. Camargo, Andrzej Fal, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1299-1299
Open Access | Times Cited: 76
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
Darius Mostaghimi, Caroline N Valdez, Haleigh Tianna Larson, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. e52-e58
Open Access | Times Cited: 57
Effectiveness of COVID-19 Vaccines against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies
Ali Pormohammad, Mohammad Zarei, Saied Ghorbani, et al.
Vaccines (2021) Vol. 10, Iss. 1, pp. 23-23
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top